Integer Holdings/$ITGR
1D1W1MYTD1Y5YMAX
Capital at risk
About Integer Holdings
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.
- Ticker
- $ITGR
- Sector
- Health
- Primary listing
- NYSE
- Employees
- 11,000
- Headquarters
- Plano, United States
- Website
- www.integer.net
Integer Holdings Metrics
BasicAdvanced
$4.3B
34.26
$3.68
0.61
-
Price and volume
Market cap
$4.3B
Beta
0.61
52-week high
$126.80
52-week low
$62.00
Average daily volume
969K
Financial strength
Current ratio
3.733
Quick ratio
2.207
Long term debt to equity
0.789
Total debt to equity
0.794
Interest coverage (TTM)
5.44%
Profitability
EBITDA (TTM)
347.701
Gross margin (TTM)
26.08%
Net profit margin (TTM)
6.97%
Operating margin (TTM)
11.04%
Effective tax rate (TTM)
5.90%
Revenue per employee (TTM)
$170,000
Management effectiveness
Return on assets (TTM)
3.86%
Return on equity (TTM)
7.50%
Valuation
Price to earnings (TTM)
34.258
Price to revenue (TTM)
2.366
Price to book
2.5
Price to tangible book (TTM)
-24.55
Price to free cash flow (TTM)
38.958
Free cash flow yield (TTM)
2.57%
Free cash flow per share (TTM)
3.24
Growth
Revenue change (TTM)
2.71%
Earnings per share change (TTM)
59.64%
3-year revenue growth (CAGR)
7.85%
10-year revenue growth (CAGR)
4.88%
3-year earnings per share growth (CAGR)
20.12%
10-year earnings per share growth (CAGR)
10.76%
What the Analysts think about Integer Holdings
Analyst ratings (Buy, Hold, Sell) for Integer Holdings stock.
Analyst projections of the future price of Integer Holdings stock.
Bulls say / Bears say
KKR will acquire all outstanding shares of Integer at $127 per share in cash, representing a 51.8% premium to the pre-review closing price and valuing the enterprise at approximately $5.7 billion (Reuters)
KKR views Integer as a platform for strategic add-on acquisitions, enabling expansion of medtech capabilities and cross-selling within its healthcare portfolio (Reuters)
Agreement with activist investor Irenic Capital in March to appoint two directors, following its acquisition of over 3% stake, enhances board oversight and aligns corporate strategy with shareholder interests (Reuters)
Q2 total sales decreased 2.6% to $464.1 million year-over-year, highlighting ongoing demand headwinds in core operations (Reuters)
GAAP operating income from continuing operations plunged 41.8% year-over-year to $34.5 million in Q2, underscoring margin pressure amid rising costs (Reuters)
Integer withdrew its financial outlook and cancelled its scheduled earnings call due to the pending KKR transaction, reducing near-term visibility on business performance (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 28 Aug 2026.
Integer Holdings Financial Performance
Revenues and expenses
Integer Holdings Earnings Performance
Company profitability
Upcoming events
No upcoming events
Integer Holdings News
AllArticlesVideos
ITGR Stock Alert: Halper Sadeh LLC is Investigating Whether Integer Holdings Corporation is Obtaining a Fair Price for its Shareholders
Business Wire2 weeks ago
Integer Holdings Corporation Investigated for Breaches of Fiduciary Duty - Contact the DJS Law Group to Discuss Your Rights – ITGR
Business Wire2 weeks ago
ITGR Investors Have Opportunity to Join Integer Holdings Corporation Fraud Investigation with SBS Law
Business Wire3 weeks ago
Funds containing Integer Holdings
AllUSDGBPEUR
Fund name | Fund size | $ITGR weighting |
|---|---|---|
iShares S&P SmallCap 600$IDP6 | $3.2B | 0.24% |
iShares S&P Small Cap 600£ISP6 | £2.4B | 0.24% |
SPDR Russell 2000 US Small Cap€R2US | €4.8B | 0.14% |
iShares MSCI World Small Cap$WSML | $9B | 0.04% |
iShares MSCI World Small Cap€IUSN | €7.8B | 0.04% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.